QT
CDMO

Quantamental Technologies’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Quantamental Technologies’s Portfolio CDMO Stock Details CDMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-3,149
Closed -$17K – 1407
2019
Q3 		$17K Buy
3,149
+2,749
+687% +$17.1K 0.01% 1240
2019
Q2 		$2K Sell
400
-100
-20% -$412 ﹤0.01% 1388
2019
Q1 		$2K Hold
500
– – ﹤0.01% 1389
2018
Q4 		$2K Buy
+500
New +$2.61K ﹤0.01% 1283

Other funds holding CDMO

ICM
ISZO Capital Management New York $2M AUM 35.61% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Quantamental Technologies's CDMO Position: Q4 2019 in Review

Quantamental Technologies sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2019, closing a stake of 3,149 shares — an estimated $17K sold.

Quantamental Technologies first reported a position in CDMO in Q4 2018 and held it in 4 quarters. The position peaked at $17K in Q3 2019. 114 funds tracked by Wall St. Rank hold CDMO as of Q4 2019.

  • Quantamental Technologies reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Quantamental Technologies sold 3,149 Avid Bioservices, Inc. Common Stock shares in Q4 2019, an estimated $17K.
  • Quantamental Technologies first reported a position in Avid Bioservices, Inc. Common Stock in Q4 2018 and held it in 4 quarters.
  • Quantamental Technologies's Avid Bioservices, Inc. Common Stock position peaked at $17K in Q3 2019.
  • 114 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2019.

Based on Quantamental Technologies's 13F filing for Q4 2019, filed 14 Feb 2020.